Holen Sie sich die Stockscreener-App
21.43
0.92%
-0.20
Handel nachbörslich:
24.28
2.85
+13.30%
Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten
Amylyx stock rises on Phase 3 trial results date - Investing.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Amylyx Pharmaceuticals Stock Soars After the Close: Here's Why - Benzinga
Amylyx to announce phase 3 trial results for hypoglycemia drug - Investing.com
Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026 - Yahoo Finance
Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $30.00 - MarketBeat
Mizuho raises Amylyx stock price target to $30 on higher pricing - Investing.com
Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $30 From $24, Keeps Outperform Rating - marketscreener.com
Amylyx Pharmaceuticals (AMLX) Stock Trades At A Premium After Avexitide Trial Progress - Yahoo Finance
Is Amylyx Pharmaceuticals (AMLX) A Bargain Following Its Q2 Loss Update? - Yahoo Finance
Amylyx Pharmaceuticals (AMLX) Is Down 7.1% After Wider Q2 Loss And Avexitide Phase III Update - Yahoo Finance
Amylyx (AMLX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Amylyx (AMLX) Quietly Rewriting Its R&D Risk‑Reward Profile As Losses Deepen Without Revenue? - Sahm
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year - TradingView
HC Wainwright Issues Pessimistic Outlook for AMLX Earnings - MarketBeat
Weekly Recap: LUCIDITY trial completion and Q2 adjusted loss cut - TradingView
Dimensional Fund Advisors LP Has $12.54 Million Stock Holdings in Amylyx Pharmaceuticals, Inc. $AMLX - marketbeat.com
A Quick Look at Today's Ratings for Amylyx Pharmaceuticals(AMLX.US), With a Forecast Between $24 to $34 - Moomoo
Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Singapore
Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild (NASDAQ:AMLX) - Seeking Alpha
Amylyx Pharmaceuticals (AMLX) Stock Analysis: Strong Buy Ratings and Promising Drug Pipeline Signal Growth Potential - DirectorsTalk Interviews
Amylyx Pharmaceuticals (NASDAQ:AMLX) Issues Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Earnings call transcript: Amylyx misses Q2 2026 EPS forecast as stock slips premarket - Investing.com Canada
Amylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $26.7, Implies 22% Upside - TradingView
Amylyx Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Amylyx Pharmaceuticals Shares Rise After Q2 Loss Narrows - marketscreener.com
Amylyx Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Amylyx Pharmaceuticals 2Q Loss/Shr 39c >AMLX - Moomoo
Transcript : Amylyx Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
Amylyx Pharmaceuticals, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q2 Loss $0.39 a Share, vs. FactSet Est of $0.35 Loss - marketscreener.com
Amylyx Pharmaceuticals, Inc. (AMLX) Q2 FY2026 earnings call transcript - Yahoo Finance
Amylyx Pharmaceuticals Q2 posts higher than expected loss - TradingView
Amylyx Pharmaceuticals, Inc. 2Q 2026: Net loss $43.4M, EPS $(0.39) — 10-Q Summary - TradingView
Amylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingView
Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results - Business Wire
Amylyx Pharmaceuticals Inc (AMLX) (Q2 2026) Earnings Call Highlights: Advancing Toward Pivotal ... By GuruFocus - Investing.com Canada
Amylyx Pharmaceuticals earnings up next as trial data looms - Investing.com
Amylyx Pharmaceuticals earnings up next as trial data looms By Investing.com - Investing.com Canada
Amylyx Pharmaceuticals stock hits 52-week high at 20.98 USD By Investing.com - Investing.com India
Amylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 12-Month High on Analyst Upgrade - MarketBeat
Amylyx Pharmaceuticals stock hits 52-week high at 20.98 USD - Investing.com
Amylyx Pharmaceuticals Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Amylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $25.56, Implies 26% Upside - TradingView
Press Release: Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026 - moomoo.com
Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
Amylyx Pharmaceuticals (NASDAQ:AMLX) Given New $26.00 Price Target at Citigroup - MarketBeat
Janus Henderson Group PLC Has $69.26 Million Stock Holdings in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Amylyx Pharmaceuticals (AMLX) to Post Quarterly Earnings on Thursday - MarketBeat
ADAR1 Capital Management LLC Buys 110,248 Shares of Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Amylyx Pharmaceuticals stock hits 52-week high at 19.19 USD - Investing.com
Amylyx Pharmaceuticals stock hits 52-week high at 19.19 USD By Investing.com - Investing.com Canada
Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 1-Year HighHere's Why - MarketBeat
Amylyx Pharmaceuticals Inc (AMLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Institutional Confidence - TradingKey
TradingKey - TradingKey
Amylyx Pharmaceuticals (AMLX) Surges Over 4%: Key Levels to WatchDay Trade Opportunities - dars.gov.et
Amylyx Pharmaceuticals Inc (AMLX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AMLX|Amylyx Pharmaceuticals Inc|Price:22.500|Chg%:-0.850 - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
1.61%
1.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):